Leading Infectious Disease Biomaterial Manufacturer

  • Copan FLOQSwab® and Liquid Control Products
    • Clinical Diagnostics,
    • Proficiency Programs,
    • Training, Verification and Development
  • Antigens for Diagnostic Test Manufacturers
  • Viral Transport Medium – DxTM™

Microbix Announces $6.0 Million of Financings

$5.0 Million Bought-Deal Public Offering and $1.0 Million Private Placement - NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE...

Microbix & SpeeDx Form Exclusive Collaboration

Focus on Diagnostics and Controls for Anti-Microbial Resistant Infections MISSISSAUGA, CANADA and EVELEIGH, AUSTRALIA April 26, 2021 – Microbix...

Microbix Receives $4.25 Million Order For Viral Transport Medium

An Initial Order From Government Of Ontario Procurement Authorities MISSISSAUGA, April 23, 2021 – Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF,...


Why choose Microbix Quality Assessment Products (QAPs)? Find out more.


Microbix produces one of the world’s broadest range of infectious disease antigens.


Microbix has a partnership opportunity. Check it out here.

Our Commitment to Quality

Our quality process ensures our customers receive products that meet and exceed their needs and expectations. Our quality management system takes into consideration regulatory requirements that are applicable to the type of products we manufacture and the industries we serve.